Does LEVALBUTEROL Cause Product packaging quantity issue? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Product packaging quantity issue have been filed in association with LEVALBUTEROL (Levalbuterol tartrate HFA inhalation). This represents 1.9% of all adverse event reports for LEVALBUTEROL.
28
Reports of Product packaging quantity issue with LEVALBUTEROL
1.9%
of all LEVALBUTEROL reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product packaging quantity issue From LEVALBUTEROL?
Of the 28 reports, 2 (7.1%) required hospitalization, and 1 (3.6%) were considered life-threatening.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVALBUTEROL. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does LEVALBUTEROL Cause?
Device delivery system issue (459)
Drug dose omission by device (395)
No adverse event (393)
Dyspnoea (224)
Drug ineffective (181)
Asthma (105)
Off label use (97)
Cough (70)
Device issue (68)
Incorrect dose administered by device (59)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which LEVALBUTEROL Alternatives Have Lower Product packaging quantity issue Risk?
LEVALBUTEROL vs LEVAMISOLE
LEVALBUTEROL vs LEVAQUIN
LEVALBUTEROL vs LEVEMIR
LEVALBUTEROL vs LEVETIRACETAM
LEVALBUTEROL vs LEVOBUNOLOL